JUDY WOODRUFF: The U.S. and its European allies
work together on many issues, but, under President
Trump, they diverge dramatically over Iran's
nuclear program.
When his administration had the U.S. withdraw
from the Iran nuclear deal last year and then
snap back sanctions on Iran, the Europeans
objected strongly.
Today, they took a major step to try and help
Iran get around those sanctions.
Here's Nick Schifrin.
NICK SCHIFRIN: When the U.S., Iran, and the
Europeans signed the 2014 nuclear deal, Iran
froze its nuclear program in exchange for
billions of dollars in economic benefits.
The Trump administration's withdrawal from
the deal meant Iran never received much of
the revenue it was promised, which is why
the Europeans today announced a company, financed
by Germany, France and U.K., that's designed
to allow Iran to both gain some of that revenue,
and keep them in the nuclear deal.
The new company is a kind of clearinghouse
that allows Iran to trade goods with foreign
companies without any money exchanged.
That means they avoid U.S. banks and U.S.
dollars, so they could avoid U.S. sanctions.
The Europeans say the first goods that Iran
will receive include drugs and medical devices,
which Iran needs.
To talk about this, I'm joined by David O'Sullivan,
the European Union ambassador to the U.S.
Ambassador, thank you very much.
Welcome back to the "NewsHour."
DAVID O'SULLIVAN, European Union Ambassador
to the United States: Thank you.
NICK SCHIFRIN: Are you trying to undermine
U.S. efforts on Iran?
DAVID O'SULLIVAN: Absolutely not.
I think the most important thing to underline
is that we, in the European Union, believe
that keeping Iran in this nuclear deal -- and
they are complying with this deal, as was
announced just this week by the CIA -- and
in return for that, they are entitled to expect
some economic benefit and some increased trade
and economic activity.
And the purpose of the announcement today
to allow this to ho happen.
And, as you say, the primary focus in the
beginning will be on goods which are not actually
under sanction at all, which are humanitarian
goods, exceptions to the sanctions regime,
but which is sometimes difficult to trade
because of the reluctance of financial bodies
to deal with anything to do with Iran.
So this will make that, we hope, easier.
NICK SCHIFRIN: Why risk exacerbating the disagreement
with the U.S.?
DAVID O'SULLIVAN: Well, we respect the decision
of administration to withdraw from the agreement.
But we imagine they also respect the fact
that we are still signatories to the agreement,
and we feel bound by it.
And it is also profoundly in Europe's security
interest to prevent Iran from developing or
obtaining nuclear weapons.
But, of course, we also share many of the
concerns of the administration on other Iranian
activities, and indeed just recently announced
sanctions in response to some of the terrorist
plots which were uncovered in Europe.
So we're trying to work with the administration,
even as we have some disagreements about this
precise deal.
NICK SCHIFRIN: As you say, the point of this
is to try and keep Iran in the deal.
Do you think it's enough?
Obviously, many companies that deal in Iran
have already said that they won't try and
use this vehicle because they fear U.S. secondary
sanctions.
DAVID O'SULLIVAN: Well, at the end of the
day, you know, companies will have to decide
whether they feel comfortable trading with
Iran, and we know that some companies may
take the decision not to, for fear of the
secondary sanctions.
But we, on the European side, are determined
to make every effort we can to continue to
allow Iran to have the commercial benefit
from this deal which was promised.
NICK SCHIFRIN: But if the focus is on drugs,
then how do you get Iran that economic benefit
that you say it needs in order to stay in
the deal?
DAVID O'SULLIVAN: Well, I think the focus
is on delivering stuff which is already permitted
under humanitarian exceptions.
But, of course, in other ways, we are also
continuing to look at ways in which we can
improve economic conditions with Iran.
There are small and medium-sized European
companies who don't necessarily trade heavily
with the United States or at all who may be
interested in doing business.
Of course it's challenging.
There's no point pretending it isn't, but
we still believe it is very much in our national
security interests to preserve this deal and
to deliver some of the benefits which Iran
is entitled to expect.
NICK SCHIFRIN: Let me read a statement from
the State Department -- or a State Department
spokesperson today -- quote -- "Entities that
continue to engage in sanctionable activity
involving Iran risk severe consequences that
could include losing access to the U.S. financial
system and the ability to do business with
the United States or U.S. companies."
Do you fear the U.S. could actually sanction
the U.K., Germany or France?
DAVID O'SULLIVAN: I think the U.S. and the
European Union are very strong strategic partners.
We respect fully the decision of this administration
to withdraw from the Iran nuclear deal.
We believe they should also respect the fact
that the European nations have decided to
remain party to this, which is sanctioned
by U.N. resolutions.
NICK SCHIFRIN: Do you think any of the U.S.
pressure on this effort is misplaced?
DAVID O'SULLIVAN: Well, we don't share the
administration's analysis, but we understand
that they take a different view, and we are
friends and allies, but sometimes we take
a different view.
And that is the case in this instance.
NICK SCHIFRIN: Two months to Brexit day.
Is the E.U. willing to renegotiate the deal,
as Prime Minister Theresa May's opponents
in Parliament have pushed her to do?
DAVID O'SULLIVAN: I think the answer has been
very clear.
We believe that the deal, as signed, or as
agreed, is the best deal.
The so-called backstop, the provision designed
to prevent the reemergence of a hard border
between Northern Ireland and the Republic
of Ireland is a failsafe mechanism.
It's an insurance mechanism.
It's not the end point we expect to reach.
We hope we can achieve the objective of no
border.
I don't think anyone sees scope for renegotiating
that at this point.
But, of course, I think people will listen
to what Mrs. May has to say.
And if there is something in there that can
be -- that can be done to be helpful, such
as the declaration on the future -- future
relations, I think people will try to be as
helpful as possible.
But it took us 18 months to negotiate this
deal.
And, in fact, the final version of the backstop
which is contained in the deal was actually
very much designed by the U.K. itself, not
something which was imposed by the European
Union.
NICK SCHIFRIN: Another option, would the European
Union be willing to extend the deadline if
the British prime minister asks for that?
DAVID O'SULLIVAN: This is legally possible.
It requires the unanimous agreement of the
other 27.
But I'm sure, if there were to be such a request,
people would listen very carefully to the
reasons for such an extension.
And I'm sure people would try to be helpful.
But I think they will need to understand what
it would be hoped could be achieved during
such a delay.
NICK SCHIFRIN: David O'Sullivan, E.U. ambassador
to the U.S., thank you very much.
DAVID O'SULLIVAN: Thank you.
